CBRE, Los Angeles, said the COVID-19 pandemic has accelerated the U.S. life sciences industry’s momentum, particularly amid the race to produce a vaccine and other medicines.
CBRE, Los Angeles, said the COVID-19 pandemic has accelerated the U.S. life sciences industry’s momentum, particularly amid the race to produce a vaccine and other medicines.